Sona Ajit Chikarmane, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Breast Neoplasms | 53 | 2024 | 20824 | 2.820 |
Why?
|
Mammography | 26 | 2023 | 2475 | 2.530 |
Why?
|
Ultrasonography, Mammary | 8 | 2020 | 250 | 1.750 |
Why?
|
Breast | 17 | 2024 | 1970 | 1.110 |
Why?
|
Lactation | 2 | 2024 | 412 | 0.980 |
Why?
|
Early Detection of Cancer | 15 | 2023 | 3086 | 0.930 |
Why?
|
Magnetic Resonance Imaging | 23 | 2024 | 35425 | 0.900 |
Why?
|
Carcinoma, Lobular | 3 | 2021 | 484 | 0.830 |
Why?
|
Calcinosis | 3 | 2023 | 1499 | 0.720 |
Why?
|
Mammary Glands, Human | 1 | 2019 | 199 | 0.610 |
Why?
|
Hemangiosarcoma | 2 | 2016 | 239 | 0.530 |
Why?
|
Hodgkin Disease | 1 | 2023 | 1415 | 0.510 |
Why?
|
Radiographic Image Enhancement | 5 | 2023 | 885 | 0.480 |
Why?
|
Hospital Information Systems | 1 | 2016 | 395 | 0.480 |
Why?
|
Ultrasonography, Interventional | 2 | 2019 | 1486 | 0.480 |
Why?
|
Neoplasms, Radiation-Induced | 2 | 2016 | 547 | 0.480 |
Why?
|
Continuity of Patient Care | 2 | 2019 | 1049 | 0.430 |
Why?
|
Preoperative Care | 1 | 2021 | 2251 | 0.420 |
Why?
|
Retrospective Studies | 27 | 2023 | 77460 | 0.420 |
Why?
|
Precancerous Conditions | 1 | 2019 | 975 | 0.410 |
Why?
|
Neoplasm Recurrence, Local | 4 | 2020 | 9240 | 0.370 |
Why?
|
Gadolinium DTPA | 3 | 2019 | 836 | 0.340 |
Why?
|
Female | 53 | 2024 | 380193 | 0.310 |
Why?
|
Radiotherapy | 1 | 2014 | 1533 | 0.300 |
Why?
|
Carcinoma | 1 | 2017 | 2375 | 0.270 |
Why?
|
Quality Improvement | 4 | 2022 | 3749 | 0.260 |
Why?
|
Electronic Health Records | 1 | 2021 | 4468 | 0.250 |
Why?
|
Humans | 60 | 2024 | 744366 | 0.240 |
Why?
|
Diagnostic Imaging | 3 | 2021 | 3508 | 0.240 |
Why?
|
Neoplasm Metastasis | 1 | 2014 | 4851 | 0.230 |
Why?
|
Hyperplasia | 3 | 2021 | 1185 | 0.230 |
Why?
|
Mass Screening | 7 | 2023 | 5253 | 0.230 |
Why?
|
Electronics | 2 | 2021 | 322 | 0.220 |
Why?
|
Magnetic Resonance Imaging, Interventional | 2 | 2017 | 182 | 0.210 |
Why?
|
Carcinoma, Intraductal, Noninfiltrating | 2 | 2021 | 948 | 0.210 |
Why?
|
Sensitivity and Specificity | 10 | 2023 | 14723 | 0.200 |
Why?
|
Contrast Media | 5 | 2019 | 5300 | 0.200 |
Why?
|
Biopsy, Needle | 3 | 2022 | 1641 | 0.200 |
Why?
|
Molecular Targeted Therapy | 1 | 2012 | 2725 | 0.190 |
Why?
|
Reproducibility of Results | 9 | 2020 | 19905 | 0.180 |
Why?
|
Middle Aged | 23 | 2023 | 213390 | 0.180 |
Why?
|
Aged | 21 | 2023 | 163288 | 0.180 |
Why?
|
Aged, 80 and over | 10 | 2023 | 57776 | 0.160 |
Why?
|
Radiography | 3 | 2024 | 7023 | 0.160 |
Why?
|
Appointments and Schedules | 1 | 2021 | 417 | 0.150 |
Why?
|
Artifacts | 2 | 2023 | 1904 | 0.140 |
Why?
|
Pattern Recognition, Automated | 2 | 2013 | 1005 | 0.140 |
Why?
|
Adult | 21 | 2023 | 214052 | 0.140 |
Why?
|
Radiology | 3 | 2021 | 2099 | 0.140 |
Why?
|
Carcinoma in Situ | 1 | 2021 | 806 | 0.130 |
Why?
|
Breast Feeding | 1 | 2023 | 1338 | 0.130 |
Why?
|
Phyllodes Tumor | 1 | 2015 | 53 | 0.130 |
Why?
|
Predictive Value of Tests | 4 | 2023 | 15078 | 0.120 |
Why?
|
Diagnosis, Computer-Assisted | 1 | 2019 | 719 | 0.120 |
Why?
|
Genes, erbB-2 | 1 | 2014 | 162 | 0.120 |
Why?
|
Aftercare | 1 | 2019 | 870 | 0.110 |
Why?
|
Emergency Service, Hospital | 1 | 2012 | 7658 | 0.110 |
Why?
|
Biopsy | 4 | 2022 | 6755 | 0.110 |
Why?
|
Survivors | 1 | 2023 | 2291 | 0.110 |
Why?
|
Neoplasm Invasiveness | 2 | 2017 | 3616 | 0.100 |
Why?
|
Interpersonal Relations | 1 | 2019 | 1425 | 0.100 |
Why?
|
Image Interpretation, Computer-Assisted | 2 | 2016 | 3326 | 0.100 |
Why?
|
Burnout, Professional | 1 | 2019 | 694 | 0.090 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 1 | 2017 | 1184 | 0.090 |
Why?
|
Genes, BRCA1 | 1 | 2014 | 781 | 0.090 |
Why?
|
Patient Selection | 2 | 2016 | 4216 | 0.090 |
Why?
|
Algorithms | 3 | 2023 | 13882 | 0.090 |
Why?
|
Statistics as Topic | 1 | 2016 | 2373 | 0.090 |
Why?
|
Receptors, Progesterone | 1 | 2014 | 1098 | 0.090 |
Why?
|
Pleural Neoplasms | 1 | 2014 | 607 | 0.090 |
Why?
|
Neoplasms | 2 | 2022 | 21696 | 0.080 |
Why?
|
Antineoplastic Agents | 1 | 2012 | 13693 | 0.080 |
Why?
|
Image Processing, Computer-Assisted | 2 | 2017 | 8949 | 0.080 |
Why?
|
Internship and Residency | 2 | 2019 | 5791 | 0.080 |
Why?
|
Carcinoma, Ductal | 1 | 2008 | 101 | 0.080 |
Why?
|
Medicare | 2 | 2023 | 6566 | 0.080 |
Why?
|
Receptors, Estrogen | 1 | 2014 | 2190 | 0.070 |
Why?
|
Vulnerable Populations | 2 | 2022 | 686 | 0.070 |
Why?
|
Curriculum | 1 | 2019 | 3605 | 0.070 |
Why?
|
Central Nervous System Neoplasms | 1 | 2014 | 895 | 0.070 |
Why?
|
Education, Medical, Graduate | 1 | 2018 | 2291 | 0.070 |
Why?
|
Mental Health | 1 | 2019 | 3010 | 0.060 |
Why?
|
Elasticity Imaging Techniques | 1 | 2010 | 388 | 0.060 |
Why?
|
Delivery of Health Care | 1 | 2023 | 5321 | 0.060 |
Why?
|
Massachusetts | 1 | 2016 | 8662 | 0.060 |
Why?
|
Artificial Intelligence | 2 | 2013 | 2213 | 0.060 |
Why?
|
Terminology as Topic | 1 | 2010 | 1547 | 0.060 |
Why?
|
Neoplasm Staging | 1 | 2017 | 11031 | 0.050 |
Why?
|
Diagnosis, Differential | 4 | 2020 | 12961 | 0.050 |
Why?
|
Bone Neoplasms | 1 | 2014 | 2530 | 0.050 |
Why?
|
United States | 4 | 2023 | 69872 | 0.050 |
Why?
|
Pregnancy | 1 | 2023 | 29144 | 0.050 |
Why?
|
Axilla | 1 | 2023 | 597 | 0.050 |
Why?
|
Family Practice | 1 | 2023 | 516 | 0.050 |
Why?
|
Medically Underserved Area | 1 | 2022 | 253 | 0.050 |
Why?
|
Prevalence | 1 | 2016 | 15221 | 0.040 |
Why?
|
Sentinel Lymph Node Biopsy | 1 | 2023 | 710 | 0.040 |
Why?
|
Liver Neoplasms | 1 | 2014 | 4253 | 0.040 |
Why?
|
Positron-Emission Tomography | 1 | 2014 | 6234 | 0.040 |
Why?
|
Prognosis | 3 | 2014 | 29060 | 0.040 |
Why?
|
Young Adult | 3 | 2023 | 56429 | 0.040 |
Why?
|
False Negative Reactions | 1 | 2017 | 588 | 0.030 |
Why?
|
Lymphatic Metastasis | 1 | 2023 | 2924 | 0.030 |
Why?
|
Paclitaxel | 1 | 2023 | 1708 | 0.030 |
Why?
|
Personal Satisfaction | 1 | 2019 | 643 | 0.030 |
Why?
|
Child | 1 | 2023 | 77709 | 0.030 |
Why?
|
Mastectomy | 1 | 2023 | 1793 | 0.030 |
Why?
|
Breast Implants | 1 | 2017 | 387 | 0.030 |
Why?
|
Receptor, erbB-2 | 1 | 2023 | 2417 | 0.030 |
Why?
|
Image Enhancement | 2 | 2013 | 2921 | 0.030 |
Why?
|
Neoadjuvant Therapy | 1 | 2023 | 2727 | 0.030 |
Why?
|
Lymph Nodes | 1 | 2023 | 3476 | 0.030 |
Why?
|
Feasibility Studies | 1 | 2022 | 5077 | 0.030 |
Why?
|
Medical Oncology | 1 | 2023 | 2267 | 0.030 |
Why?
|
Tomography, X-Ray Computed | 1 | 2014 | 20130 | 0.020 |
Why?
|
Risk Factors | 2 | 2017 | 72296 | 0.020 |
Why?
|
Observer Variation | 1 | 2017 | 2593 | 0.020 |
Why?
|
Vacuum | 1 | 2010 | 65 | 0.020 |
Why?
|
Lung Neoplasms | 1 | 2014 | 13104 | 0.020 |
Why?
|
Health Personnel | 1 | 2023 | 3219 | 0.020 |
Why?
|
Adolescent | 2 | 2016 | 85779 | 0.020 |
Why?
|
Periodicals as Topic | 1 | 2021 | 1431 | 0.020 |
Why?
|
Markov Chains | 1 | 2013 | 969 | 0.020 |
Why?
|
Prospective Studies | 3 | 2023 | 53290 | 0.020 |
Why?
|
Health Services Accessibility | 1 | 2022 | 5135 | 0.020 |
Why?
|
Boston | 1 | 2017 | 9312 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2019 | 13991 | 0.010 |
Why?
|
Data Interpretation, Statistical | 1 | 2013 | 2716 | 0.010 |
Why?
|
Comorbidity | 1 | 2017 | 10388 | 0.010 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2023 | 11525 | 0.010 |
Why?
|
Anticoagulants | 1 | 2017 | 4600 | 0.010 |
Why?
|
Pandemics | 1 | 2021 | 8385 | 0.010 |
Why?
|
Analysis of Variance | 1 | 2010 | 6366 | 0.010 |
Why?
|
Models, Statistical | 1 | 2013 | 5101 | 0.010 |
Why?
|
Models, Biological | 1 | 2013 | 9584 | 0.010 |
Why?
|
Time Factors | 1 | 2010 | 40075 | 0.000 |
Why?
|
Treatment Outcome | 1 | 2012 | 63107 | 0.000 |
Why?
|